跳至主要内容
临床试验/IRCT201207243799N3
IRCT201207243799N3已完成2 期

Effects of Vitamin C in Prevention of Atrial Fibrillation after coronary artery bypass graft (A Placebo-Controlled Randomized Clinical Trial)

Tehran University of Medical Sciences Vice chancellor for research0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Inclusion Criteria: Patients with coronary artery disease (on angiography) who are candidate for coronary artery bypass.

排除标准

  • 1- Patients above 80 years old. 2- Patients who have Atrial Fibrillation before surgery. 3- Patients with heart valve disease or arrhythmia or having every degree of heart block conduction. 4- Patients who use a pacemaker. 5- Patients who have chronic lung, liver or kidney disease. 6- Patients who have other heart surgeries simultaneously with bypass surgery. 7- History of using anti-arrhythmic drugs. 8- Having sick sinus syndrome. 9- Having symptoms of urinary stone or history of kidney stones. 10- History of using Vitamin C in the recent quarter.

研究者

发起方
Tehran University of Medical Sciences Vice chancellor for research

相似试验